Lier Chemical (002258)2023-04-24 16:00Financial Performance - The company's revenue for Q1 2023 was ¥2,442,238,961.34, a decrease of 6.53% compared to ¥2,612,935,661.17 in the same period last year[5] - Net profit attributable to shareholders was ¥274,738,068.68, down 48.58% from ¥534,331,688.15 year-on-year[5] - Basic earnings per share fell by 52.63% to ¥0.3432 from ¥0.7245 in the same period last year[5] - In Q1 2023, the net profit of Lier Chemical Co., Ltd. was CNY 342,029,168.28, a decrease of 42.2% compared to CNY 591,086,437.05 in Q1 2022[20] - The company's operating profit for Q1 2023 was CNY 403,195,762.83, down 42.6% from CNY 700,540,696.90 in the same period last year[20] - Total comprehensive income attributable to the parent company was CNY 274,738,068.68, down 48.6% from CNY 534,331,688.15 in Q1 2022[21] - Basic earnings per share for Q1 2023 were CNY 0.3432, a decrease of 52.6% from CNY 0.7245 in the same quarter last year[21] Cash Flow and Investments - The net cash flow from operating activities decreased by 39.47% to ¥123,955,733.40 from ¥204,771,003.87 in the previous year[5] - Cash flow from operating activities for Q1 2023 was CNY 123,955,733.40, a decline of 39.3% compared to CNY 204,771,003.87 in Q1 2022[22] - The company reported a net cash outflow from investing activities of CNY 703,479,356.00, worsening from CNY 309,682,113.96 in the previous year[23] Assets and Liabilities - Total assets increased by 6.20% to ¥13,663,798,916.24 compared to ¥12,866,345,708.15 at the end of the previous year[5] - Total liabilities increased to CNY 5,360,897,789.58 from CNY 4,483,335,442.13, an increase of 19.5%[18] - The company's equity attributable to shareholders decreased to CNY 7,148,862,668.32 from CNY 7,269,668,905.14, a decline of 1.7%[18] Operating Costs and Expenses - The total operating costs increased to CNY 2,044,281,131.94, up 6.5% from CNY 1,919,660,705.54 year-on-year[19] - The company incurred financial expenses of CNY 29,987,879.75, an increase of 21.1% from CNY 24,730,210.15 in Q1 2022[20] Research and Development - The company's R&D expenses rose by 55.49% to ¥9,752.61 from ¥6,272.32 in the previous year, indicating increased investment in innovation[11] - Research and development expenses increased to CNY 97,526,071.23, up 55.5% from CNY 62,723,198.01 in Q1 2022[20] Shareholder Information - The company recorded a total of 58,015 common shareholders at the end of the reporting period[12] Other Financial Metrics - The weighted average return on equity decreased to 3.71% from 10.19% in the previous year, indicating a decline in profitability[5] - The company reported a net profit margin decline due to increased costs, impacting overall profitability[19] - Cash and cash equivalents at the end of Q1 2023 were CNY 1,353,582,752.50, slightly down from CNY 1,333,738,748.44 at the end of Q1 2022[23] - Accounts receivable rose to CNY 1,628,660,818.38 from CNY 1,588,107,170.85 at the start of the year, indicating a growth of 2.3%[16] - Inventory decreased to CNY 1,642,894,394.51 from CNY 1,709,758,816.00, reflecting a decline of 3.9%[17] - Short-term borrowings increased significantly to CNY 295,209,305.55 from CNY 132,475,216.16, marking a rise of 123.5%[18] - The company reported a significant increase in prepayments, which rose by 63.34% to ¥14,608.30, primarily due to increased procurement of raw materials[11]